Skip to content

Fidelity National Financial FNF Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Apollo Global Management logo
Apollo Global ManagementAPO
90B0.0%
KKR & Co. logo
KKR & Co.KKR
3.5B0.0%
MetLife logo
MetLifeMET
Reinsurance Group of America logo
Reinsurance Group of AmericaRGA
Corebridge Financial logo
Corebridge FinancialCRBG
American Financial Group logo
American Financial GroupAFG

Other financials

Income statement

See full
Revenue$3.2B+18.2%
Net income$243.0M+193%
EPS (diluted)$0.90+200%

Balance sheet

See full
Cash & equivalents$2.5B-45.0%
Total debt$4.8B-0.7%
Total equity$7.3B-8.1%
Total assets$111.50B+13.5%

Cash flow

See full
Operating cash flow$875.0M-21.5%

Valuation

See full
Market cap$12.6B-29.7%
Enterprise value$14.9B-18.3%
P/E13.1×
P/S0.8×-0.5×

Profitability

See full
Net margin8.3%

Returns & leverage

See full
Return on equity14.2%
Debt / equity0.7×0.0×

Where this comes from

Reported directly by Fidelity National Financial in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Fidelity National Financial’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fidelity National Financial's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fidelity National Financial's common stock, shares authorized (in shares)?
Fidelity National Financial (FNF) reported common stock, shares authorized (in shares) of $600M in Q1 2026.
How has Fidelity National Financial's common stock, shares authorized (in shares) changed year-over-year?
Fidelity National Financial's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $600M to $600M.
What is the long-term trend for Fidelity National Financial's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Fidelity National Financial's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $600M to $600M.